Mr. Chair, I can start, and I will give it to Mr. Szumski to finalize it.
The Government of Canada has been able to procure about 17,000 doses of Bamlanivimab, and they have been distributed across the jurisdictions for their use, according to their clinical guidance. There have also been additional efforts to bring together Eli Lilly and the provinces and territories to get more evidence to be able to see where and how it could be used.
That's what we have done at this point. I don't know if there is anything else to add.